Mirels' rating for humerus lesions is both reproducible and valid

Clinical Orthopaedics and Related Research

Volumn 466, Issue 6, 2008, Pages 1279-1284

  Evans, Andrew R ^a   Bottros, John ^b   Grant, William ^a   Chen, Benjamin Y ^a   Damron, Timothy A ^a,c  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Musculoskeletal Sciences Research Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE METASTASIS; BONE RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL EDUCATION; CONFERENCE PAPER; HUMAN; HUMERUS; HUMERUS FRACTURE; PATHOLOGIC FRACTURE; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SENSITIVITY AND SPECIFICITY; ADULT; AGED; ARTICLE; BONE TUMOR; COHORT ANALYSIS; FEMALE; HEALTH SURVEY; MALE; METASTASIS; MIDDLE AGED; PAIN ASSESSMENT; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; REPRODUCIBILITY; RISK ASSESSMENT; ROC CURVE;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; COHORT STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HUMERAL FRACTURES; HUMERUS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; ROC CURVE;

EID: 44949198393     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-008-0200-0     Document Type: Conference Paper

References (12)

1. Coleman RE. Metastatic bone disease: clinical features, pathophysiology, and treatment strategies. Cancer Treat Rev. 2001;27:165-176.
2. Damron TA, Morgan H, Prakash D, Grant W, Aronowitz J, Heiner J. Metastatic disease of long bones: critical evaluation of Mirels' Rating System for impending pathologic fractures. Clin Orthop Relat Res. 2003;415S:S201-S207.
3. Fidler M. Prophylactic internal fixation of secondary neoplastic deposits in long bones. BMJ. 1973;1:341-343.
4. Flemming JE, Beals RK. Pathologic fractures of the humerus. Clin Orthop Relat Res. 1986;203:258-260.
5. Green AG. Kappa Statistics for Multiple Raters Using Categorical Classifications. Proceedings of the Twenty-Second Annual SAS Users Group International Conference. Cary NC: SAS Institute; 1997.
6. Harrington KD. Impending pathologic fractures from metastatic malignancy: evaluation and management. Instr Course Lect. 1986;35:357-381.
7. Hipp JA, Springfield DS, Hayes WC. Predicting pathologic fracture risk in the management of metastatic bone defects. Clin Orthop Relat Res. 1995;312:120-135.
8. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
9. Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989;249:256-264.
10. Parrish FF, Murray JA. Surgical treatment for secondary neoplastic fractures. J Bone Joint Surg Am. 1970;52:665-686.
11. Snell WE, Beals RK. Femoral metastases and fracture from breast cancer. Surg Gynecol Obstet. 1964;119:22-24.
12. Zickel RE, Mouradian WH. Intramedullary fixation of pathological fractures and lesions of the subtrochanteric region of the femur. J Bone Joint Surg Am. 1976;58:1061-1066.